Latest filing published 02 Mar 2020 for Akebia Therapeutics, Inc., €27k.
Filing timeline
BuySaleInsider track record
Karen L. Tubridy: trading record in brief
Karen L. Tubridy discloses dealings in 2 companies, chiefly Akebia Therapeutics, Inc. and Sesen Bio, Inc. Between 26 June 2015 and 28 February 2020, the trades on record add up to 10 filings.
On the market, this insider has only sold: 3 sales, €47k in total. Besides market trades, the filings include 6 share grants. In 2020 alone, the filings show no purchases and 1 sale.
The record was last updated on 2 March 2020 with an open-market sale (€27k) in Akebia Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Karen L. Tubridy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,454 shares@ US$8.70100.0% of flowCommon StockSEC:0001562180-20-001934:1
- 30,000 shares0Common StockSEC:0001562180-20-001934:0
- 6,075 shares@ US$7.7025.5% of flowCommon StockSEC:0000899243-19-010588:0
- 30,000 shares0Common StockSEC:0001562180-19-001680:0
- 11,928 shares@ US$8.9457.8% of flowCommon StockSEC:0000899243-18-030797:0
- 17,500 shares0Common StockSEC:0001562180-18-001382:0
- 23,000 shares0Common StockSEC:0001562180-17-000882:0
- 4,372 shares@ US$2.08100.0% of flowCommon StockSEC:0001485003-16-000122:0
- 4,427 shares@ US$2.85Common StockSEC:0001485003-15-000032:0
- 37,400 shares0Common StockSEC:0001209191-15-057093:0
10 of 10 declarations
